Polycystic kidney disease epidemiology and demographics
Polycystic kidney disease Microchapters |
Differentiating Polycystic kidney disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polycystic kidney disease epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Polycystic kidney disease epidemiology and demographics |
FDA on Polycystic kidney disease epidemiology and demographics |
CDC on Polycystic kidney disease epidemiology and demographics |
Polycystic kidney disease epidemiology and demographics in the news |
Blogs on Polycystic kidney disease epidemiology and demographics |
Risk calculators and risk factors for Polycystic kidney disease epidemiology and demographics |
Steven C. Campbell, M.D., Ph.D. Cafer Zorkun, M.D., Ph.D. [1]
Epidemiology
Polycystic kidney disease is the most common life-threatening genetic disease, affecting approximately 7 million people worldwide. Autosomal dominant polycystic kidney disease affects up to 1 in 1000 people, while the autosomal recessive type is estimated to occur in approximately 1 in 20,000 people.[1][2]
References
- ↑ DALGAARD OZ (1957). "Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families". Acta Med. Scand. Suppl. 328: 1–255. PMID 13469269.
- ↑ Zerres K, Mücher G, Becker J; et al. (1998). "Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology". Am. J. Med. Genet. 76 (2): 137–44. PMID 9511976.